“Arimidex Direct” Program Will Provide Branded Cancer Drug To U.S. Patients For $40 A Month
This article was originally published in The Pink Sheet Daily
Executive Summary
Spurred on by patient requests for affordable access to the branded version of now generic anastrozole, AstraZeneca will partner with Express Scripts to provide the drug direct to patients at a fixed co-payment.